Product NDC: | 0093-7618 |
Proprietary Name: | Dorzolamide Hydrochloride |
Non Proprietary Name: | Dorzolamide Hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; Dorzolamide Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-7618 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078756 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100128 |
Package NDC: | 0093-7618-43 |
Package Description: | 1 BOTTLE in 1 CARTON (0093-7618-43) > 10 mL in 1 BOTTLE |
NDC Code | 0093-7618-43 |
Proprietary Name | Dorzolamide Hydrochloride |
Package Description | 1 BOTTLE in 1 CARTON (0093-7618-43) > 10 mL in 1 BOTTLE |
Product NDC | 0093-7618 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dorzolamide Hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20100128 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | DORZOLAMIDE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |